Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP864491.RAP_jqymceUPk9_pSZIprqPmZk_TOBx997mBczwd5-pRc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP864491.RAP_jqymceUPk9_pSZIprqPmZk_TOBx997mBczwd5-pRc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP864491.RAP_jqymceUPk9_pSZIprqPmZk_TOBx997mBczwd5-pRc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP864491.RAP_jqymceUPk9_pSZIprqPmZk_TOBx997mBczwd5-pRc130_provenance.
- NP864491.RAP_jqymceUPk9_pSZIprqPmZk_TOBx997mBczwd5-pRc130_assertion description "[The use of reverse-transcription polymerase chain reaction (RT-PCR) for the detection of the PML-RARA and RARA-PML fusion genes is the only technique that defines the PML breakpoint type and that allows the definition of a correct strategy for subsequent minimal residual disease (MRD) monitoring.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP864491.RAP_jqymceUPk9_pSZIprqPmZk_TOBx997mBczwd5-pRc130_provenance.
- NP864491.RAP_jqymceUPk9_pSZIprqPmZk_TOBx997mBczwd5-pRc130_assertion evidence source_evidence_literature NP864491.RAP_jqymceUPk9_pSZIprqPmZk_TOBx997mBczwd5-pRc130_provenance.
- NP864491.RAP_jqymceUPk9_pSZIprqPmZk_TOBx997mBczwd5-pRc130_assertion SIO_000772 16502581 NP864491.RAP_jqymceUPk9_pSZIprqPmZk_TOBx997mBczwd5-pRc130_provenance.
- NP864491.RAP_jqymceUPk9_pSZIprqPmZk_TOBx997mBczwd5-pRc130_assertion wasDerivedFrom befree-20140225 NP864491.RAP_jqymceUPk9_pSZIprqPmZk_TOBx997mBczwd5-pRc130_provenance.
- NP864491.RAP_jqymceUPk9_pSZIprqPmZk_TOBx997mBczwd5-pRc130_assertion wasGeneratedBy ECO_0000203 NP864491.RAP_jqymceUPk9_pSZIprqPmZk_TOBx997mBczwd5-pRc130_provenance.
- befree-20140225 importedOn "2014-02-25" NP864491.RAP_jqymceUPk9_pSZIprqPmZk_TOBx997mBczwd5-pRc130_provenance.